4//SEC Filing
STANKOVICH THOMAS 4
Accession 0001235802-23-000077
CIK 0001427570other
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 4:07 PM ET
Size
5.0 KB
Accession
0001235802-23-000077
Insider Transaction Report
Form 4
STANKOVICH THOMAS
Chief Financial Officer
Transactions
- Sale
Common Stock, $0.001 par value per share
2023-07-06$1.47/sh−106$156→ 23,384 total
Footnotes (1)
- [F1]On July 22, 2021, Mr. Stankovich was awarded an aggregate of 7,455 restricted stock units, all of which, including the unvested portion, were reported on a Form 4 filed on September 17, 2021. The shares reported under this Form 4 as being disposed of were sold to cover taxes in connection with the vesting of a portion of those previously reported restricted stock units.
Documents
Issuer
ReShape Lifesciences Inc.
CIK 0001427570
Entity typeother
Related Parties
1- filerCIK 0001181166
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 4:07 PM ET
- Size
- 5.0 KB